October 31, 2012
Astellas Pharma launched on October 31 its DTP-IPV (diphtheria, tetanus, pertussis, and inactivated polio) vaccine Quattrovac Subcutaneous Injection Syringe (adsorbed purified pertussis-diphtheria-tetanus-inactivated polio (Sabin strain) combined vaccine). The vaccine will be introduced into the public immunization program on November 1...read more